LRP6 and melanoma: Functionally, according to the gain- and loss-function experiment results, it could be found that miR-610 possessed the function of inhibiting proliferation, cycle progression and promoted apoptosis, at least partially by targeting LRP6 in vitro and vivo. Furthermore, miR-610 was inversely associated with LRP6 expression, which was overexpressed in melanoma tissues.